On May 17, 2010, Universal Health Services, Inc. (“UHS”) and Psychiatric Solutions, Inc. (“PSI”) announced that they had reached a definitive agreement whereby UHS will acquire PSI for a price of $33.75 per share in cash, or approximately $2 billion. Including the assumption of approximately $1.1 billion in PSI net debt, the total transaction consideration is approximately $3.1 billion. Cravath is representing UHS in connection with this transaction. The transaction was unanimously approved by the Board of Directors of UHS. PSI’s Board of Directors, acting on the unanimous recommendation of the Special Committee, has approved the transaction and recommends that PSI shareholders approve the merger. UHS expects to complete the transaction in the fourth quarter of 2010, subject to customary closing conditions, including regulatory approvals and approval by PSI’s shareholders.
The Cravath team includes partner Minh Van Ngo and associates Joseph D. Zavaglia, Brandon R. DeFrehn and Anish Monga on corporate matters; associates Christopher D. Belelieu and Meredith A. Hendrix on antitrust matters; partner Stephen L. Gordon and associate Matthew Cantor on tax matters; partner Eric W. Hilfers and associate Edward S. Wei on executive compensation and benefits matters; and partner Jeffrey A. Smith on environmental matters.
Deals & Cases
June 17, 2024
Cravath represented the initial purchasers in connection with the $1.225 billion 144A/Reg. S high‑yield senior secured notes offering of CHS/Community Health Systems, Inc. CHS/Community Health Systems, Inc., together with its parent company, Community Health Systems, Inc., is one of the nation’s largest healthcare companies. The transaction closed on June 5, 2024.
Deals & Cases
January 24, 2024
Cravath represented the initial purchasers in connection with the $1 billion 144A/Reg. S high‑yield senior secured notes offering of CHS/Community Health Systems, Inc. CHS/Community Health Systems, Inc., together with its parent company, Community Health Systems, Inc., is one of the nation’s largest healthcare companies. Cravath also represented the dealer manager in connection with the concurrent $985 million cash tender offer. The high‑yield senior secured notes offering closed on December 22, 2023, and the cash tender offer closed on January 10, 2024.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2025 Cravath, Swaine & Moore LLP.